Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies
Introduction: In patients with myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLAS
You're invited to celebrate with us! Find how you can participate here:
Aplastic Anemia Myelodysplastic Syndromes (MDS) Paroxysmal Nocturnal Hemoglobinuria (PNH) Donate
Introduction: In patients with myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLAS
A biosimilar is a type of biologic medication. The term “biosimilar” means that the medication is highly similar to the already approved brand name biologic (“originator” medication). Biosimilars are not generic versions of the original biologic.
Clinical research Clinical research: A type of research that involves individual persons or a group of people.
Romiplostim Romiplostim: Romiplostim is in a class of medications called thrombopoietin receptor agonists. It works by causing the cells in the bone marrow to produce more platelets.
Deferoxamine Deferoxamine: Deferoxamine is an iron-binding agent that belongs to a class of drugs known as heavy metal antagonists.